Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1361 Articles

Lee Jackson | Dec 28, 2020 at 8:50 AM EST

Why 5 Dividend-Paying Dow Jones Industrials Are Great 2021 Stocks to Buy

While positive earnings could continue to drive the major indexes higher in 2021, a very overbought and fully valued market…

Lee Jackson | Dec 10, 2020 at 9:50 AM EST

5 Dividend-Paying Pharmaceutical Stocks to Buy for Solid 2021 Total Return

Rotating from overbought and crowded momentum stocks makes sense now. From a total return standpoint, dividend-paying large-cap pharmaceutical stocks may…

Jon C. Ogg | Nov 17, 2020 at 6:49 AM EST

Warren Buffett Makes Monumental Changes in Bank, Pharma, Tech Stock Holdings

Some rather significant changes were made in the Berkshire Hathaway equity portfolio during the third quarter.

Lee Jackson | Oct 14, 2020 at 8:29 AM EDT

Wall Street Fund Managers Love These 5 Large Cap Health Care Stocks

Health care is one sector that continues to draw a ton of fund manager interest, and with good reason. These…

Chris Lange | Oct 13, 2020 at 10:56 AM EDT

Are Earnings Enough to Counter COVID-19 Study Setback at Johnson & Johnson?

Johnson & Johnson released better than expected quarterly results before the markets opened on Tuesday, but it also announced a…

Chris Lange | Oct 11, 2020 at 6:15 AM EDT

Citigroup, Goldman Sachs, Johnson & Johnson, Walgreens and More Major Earnings This Week

A new earnings reporting season kicks off this week, with the big banks and a few other companies leading the…

Chris Lange | Oct 2, 2020 at 11:58 AM EDT

Where We Stand on a Vaccine After Trump Catches COVID-19

President Trump and the First Lady have tested positive for COVID-19. That begs the question, now more than ever, of…

Lee Jackson | Sep 30, 2020 at 7:42 AM EDT

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

These companies have a very good shot at crossing the finish line first with a COVID-19 vaccine. Even those that…

Jon C. Ogg | Sep 23, 2020 at 10:48 AM EDT

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

The race for the COVID-19 vaccine is still very much on, and Johnson & Johnson just announced the launch of…

Jon C. Ogg | Sep 8, 2020 at 3:27 PM EDT

What Does a Perfect COVID-19 Vaccine Actually Mean?

The race for finding the COVID-19 vaccine is in full swing, and it has just seen one team move ahead…

Jon C. Ogg | Sep 2, 2020 at 7:27 PM EDT

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

America and the rest of the world is getting ready for a vaccine that will help protect public health against…

Jon C. Ogg | Sep 1, 2020 at 8:46 AM EDT

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Three U.S. COVID-19 vaccine trials are now in Phase 3 studies. All three appear to have some serious benefits, but…

Chris Lange | Aug 19, 2020 at 11:33 AM EDT

Johnson & Johnson’s Newest Multibillion Dollar Acquisition

After Momenta Pharmaceuticals announced that it would be acquired by pharmaceutical giant Johnson & Johnson, the biotechnology company's shares soared…

Chris Lange | Jul 30, 2020 at 11:54 AM EDT

Johnson & Johnson Takes the Next Big Step in Fighting COVID-19

Johnson & Johnson has announced that it will launch its human study for its lead vaccine candidate in the United…

Jon C. Ogg | Jul 28, 2020 at 1:42 PM EDT

Beyond COVID-19, Credit Suisse Shows Its Top Health Care Recovery Stock Picks

Credit Suisse has assembled its favorite health care recovery stocks for a recovering base of elective surgeries and for the…

1 … 34 35 36 37 38 … 91

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Why 5 Dividend-Paying Dow Jones Industrials Are Great 2021 Stocks to Buy

5 Dividend-Paying Pharmaceutical Stocks to Buy for Solid 2021 Total Return

Warren Buffett Makes Monumental Changes in Bank, Pharma, Tech Stock Holdings

Wall Street Fund Managers Love These 5 Large Cap Health Care Stocks

Are Earnings Enough to Counter COVID-19 Study Setback at Johnson & Johnson?

Citigroup, Goldman Sachs, Johnson & Johnson, Walgreens and More Major Earnings This Week

Where We Stand on a Vaccine After Trump Catches COVID-19

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

What Does a Perfect COVID-19 Vaccine Actually Mean?

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Johnson & Johnson’s Newest Multibillion Dollar Acquisition

Johnson & Johnson Takes the Next Big Step in Fighting COVID-19

Beyond COVID-19, Credit Suisse Shows Its Top Health Care Recovery Stock Picks

Arizonans Don’t Retire in Scottsdale. Here’s Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Two Latin Words on Your Beneficiary Form Decide Whether Your Grandchildren Inherit Their Late Parent’s Share or Watch It Get Split Among the Aunts and Uncles

Arizonans Don't Retire in Scottsdale. Here's Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Arizonans Don’t Retire in Scottsdale. Here’s Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Why 5 Dividend-Paying Dow Jones Industrials Are Great 2021 Stocks to Buy

5 Dividend-Paying Pharmaceutical Stocks to Buy for Solid 2021 Total Return

Warren Buffett Makes Monumental Changes in Bank, Pharma, Tech Stock Holdings

Wall Street Fund Managers Love These 5 Large Cap Health Care Stocks

Are Earnings Enough to Counter COVID-19 Study Setback at Johnson & Johnson?

Citigroup, Goldman Sachs, Johnson & Johnson, Walgreens and More Major Earnings This Week

Where We Stand on a Vaccine After Trump Catches COVID-19

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

What Does a Perfect COVID-19 Vaccine Actually Mean?

As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Johnson & Johnson’s Newest Multibillion Dollar Acquisition

Johnson & Johnson Takes the Next Big Step in Fighting COVID-19

Beyond COVID-19, Credit Suisse Shows Its Top Health Care Recovery Stock Picks

Arizonans Don’t Retire in Scottsdale. Here’s Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.

Two Latin Words on Your Beneficiary Form Decide Whether Your Grandchildren Inherit Their Late Parent’s Share or Watch It Get Split Among the Aunts and Uncles

Featured Reads

Arizonans Don't Retire in Scottsdale. Here's Where They Actually Go

At 64, He Moved His 401(k) Away From Stocks. Wall Street May Bring AI Risk Back Through the Bond Side.